Quanta Pharma Tesamorelin 10mg

is a pharmaceutical-grade

GHRH analogue peptide

, a 44 amino acid synthetic version of growth hormone-releasing hormone, originally developed to target visceral adipose tissue reduction. This lyophilised vial from

Quanta Pharma

offers researchers a high-purity compound for advanced studies in visceral fat metabolism, endogenous growth hormone secretion, IGF-1 elevation, and cognitive function research. Two independent Analiza Białek tests confirm the finished vial, most recently at 10.26mg content and 99% purity. Available for

UK delivery

with fast dispatch.

Independently Lab Verified

Two finished product tests by an independent EU laboratory

Reports

Labs

Purity

Finished Product Test (Sealed Vial)

New Just Tested

ANALIZA BIAŁEK

Actual Content

Label Claim

Purity

Sample:

Sealed lyophilised vial  |

Order:

100015231  |

Method:

HPLC (BioBasic 8 Thermo Scientific)  |

Verification Key:

M8Y6V4Z2

Tested 15 June 2026

Finished Product Test (Sealed Vial)

ANALIZA BIAŁEK

Actual Content

Label Claim

Purity

Sample:

Sealed production vial  |

Order:

100014033  |

Tested:

April 2026  |

Verification Key:

79D5TN2F

Quanta Pharma Tesamorelin Specifications

Peptide

Tesamorelin

Also Known As

Egrifta, TH9507

Dosage

10mg/vial

Class

GHRH Analogue

Structure

44 Amino Acids

Form

Lyophilised

Half-Life

~26 Minutes

Storage

2-8°C

Tesamorelin 10mg

Quanta Pharma

Quanta Pharma Tesamorelin Research Benefits

Visceral adipose tissue reduction

: The only GHRH analogue with clinical research specifically demonstrating targeted reduction of visceral fat around the abdominal organs, with effect sizes typically in the 15 to 20 percent range

Endogenous GH pulses

: Stimulates the pituitary to release the body’s own growth hormone in natural, pulsatile fashion rather than creating a constant supraphysiological level

IGF-1 elevation

: Researched for meaningful and sustained increases in serum IGF-1, the downstream mediator of most anabolic growth hormone effects

Cognitive function studies

: Investigated in research populations for effects on memory, executive function, and cognitive performance in older adults

Lipid profile support

: Studies report favourable shifts in triglycerides and non-HDL cholesterol alongside the reductions in visceral fat

Preserves subcutaneous fat and lean tissue

: Unlike direct HGH administration, effects are concentrated on visceral fat without meaningful loss of subcutaneous fat or lean mass

How Quanta Pharma Tesamorelin Works

Tesamorelin

is a synthetic 44 amino acid analogue of human growth hormone-releasing hormone (GHRH), stabilised by the addition of a trans-3-hexenoic acid group at the N-terminus. This modification dramatically extends the peptide’s half-life in circulation compared to native GHRH, which is degraded within minutes by the enzyme dipeptidyl peptidase-4 (DPP-4).

Rather than supplying exogenous growth hormone directly,

Quanta Pharma Tesamorelin

What sets

Quanta Pharma Tesamorelin

Quanta Pharma Tesamorelin vs CJC-1295 and Ipamorelin

Whilst CJC-1295 and Ipamorelin are popular GHRH and GHRP peptides,

Quanta Pharma Tesamorelin

precisely because it is the most clinically validated peptide in this space.

Why Choose Quanta Pharma Tesamorelin?

Quanta Pharma

is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. The 10mg vial of

Quanta Pharma Tesamorelin

⚠️ FOR LABORATORY RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Safety Classification:

For use by qualified research personnel only. Keep detailed records of usage and storage as per UK research regulations.

Legal Notice:

This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.